Abstract
Cardiovascular diseases secondary to accelerated atherosclerosis are now accepted as a cause of mortality and morbidity in patients suffering from systemic lupus erythematosus and rheumatoid arthritis. More recently, atherosclerosis is emerging as one of the most serious complications in the anti-phospholipid syndrome, although large epidemiological studies, such as those performed in lupus and rheumatoid arthritis patients, have not been performed up to now.
Classical risk factors (dislipidemia, hypertension, diabetes, smoking, etc.) and steroid therapy cannot completely explain the high prevalence of cardiovascular complications in systemic autoimmune diseases. Since the modern view defines atherosclerosis as a chronic inflammatory disorder, it has been suggested that systemic inflammation and soluble immune mediators (circulating autoantibodies, immune-complexes, complement activation products) might play a role in accelerating vessel pathology. The main target appears to be the endothelium because of its ability to switch to a pro-adhesive, pro-inflammatory and pro-coagulant surface in response to these mediators.
Recent advances in the knowledge of the pharmacology of statins have indicated that these drugs rather than to be simple cholesterol lowering molecules display a pleiotropic effects on several mechanisms involved in the atherosclerotic plaque formation. Their anti-inflammatory activity and particularly their ability to downregulate endothelial cell activation induced by different stimuli strongly suggest their possible use in conditions in which the systemic inflammation and the endothelial activation/damage are through to represent key pathogenic mechanisms.
Similar content being viewed by others
References
Ross, R. (1999), N. Engl. J. Med. 340, 115–126.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., et al. (1998), Blood 91, 3527–3561.
Bombeli, T., Schwartz, B. R., and Harlan, J. M. (1998), J. Exp. Med. 187, 329–339.
Glagov, S., Weisenberg, E., Zarins, CK., Stankunavicius, R., and Kolettis, G.J. (1987), N. Engl. J. Med. 316, 1371–1375.
Schonbeck, U., Mach, F., Sukhova, G. K., Murphy, C., Bonnefoy, J. Y., Fabunmi, R. P., and Libby, P. (1997), Circ. Res. 81, 448–454.
Galis, Z. S., Sukhova, G. K., Lark, M. W., and Libby, P. (1994), J. Clin. Invest. 94, 2493–2503.
Manzi, S. (2000), Rheumatology 39, 353–359.
Wollheim, F. A. (2001), Curr. Opin. Rheumatol. 13, 193–201.
George, J., Haratz, D., and Shoenfeld, Y. (2001), Rheum. Dis. Clin. North Am. 27, 603–610.
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jr., Jansen-McWilliams, L., et al. (1997), Am. J. Epidemiol. 145, 408–415.
Petri, M., Perez-Gutthann, S., Spence, D., and Hochberg, M. C. (1992), Am. J. Med. 93, 513–519.
Ward, M. M. (1999), Arthritis Rheum. 42, 338–346.
Bruce, I. N., Gladman, D. D., and Urowitz, M. B. (2000), Rheum. Dis. Clin. North Am. 26, 257–278.
Libby, P., Ridker, P. M., and Maseri, A. (2002), Circulation 105, 1135–1143.
Tedesco, F., Fischetti, F., Pausa, M., Dobrina, A., Sim, R. B., and Daha, M. R. (1999), Mol. Immunol. 36, 261–268,
Praprotnik, S., Blank, M., Meroni, P. L., Rozman, B., Eldor, A., and Shoenfeld, Y. (2000), Arthritis Rheum. 44, 1484–1494.
Hollenbaugh, D., Mischel Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., et al. (1995), J. Exp. Med. 182, 33–40.
Schonbeck, U., Mach, F., Bonnefoy, J. Y., Loppnow, H., Flad, H. D., and Libby, P. (1997), J. Biol. Chem. 272, 19569–19574.
Haverkate, F., Thompson, S. G., Pyke, S. D., Gallimore, J. R., and Pepys, M. B. (1997), Lnacet 349, 462–466.
Kannel, W. B., Wolf, P. A., Castelli, W. P., and D'Agostino, R. B. (1987), Am. Med. Assoc. 258, 1183–1186.
Wierzbichin, A. S. (2000), Lupus 9, 194–201.
Wallberg-Jonsson, S., Johansson, H., Ohman, M. L., and Rantapaa-Dahlqvist, S. (1999), J. Rheumatol. 26, 2562–2571.
Wallberg-Jonsson, S., Cederfelt, M., and Rantapaa Dahlqvist, S. (2000), J. Rheumatol. 27, 71–75.
Jacobsson, L. T., Turesson, C., Hanson, R. L., Pillemer, S., Sievers, M. L., Pettitt, D. J., et al. (2001), Arthritis Rheum. 44, 1170–1176.
Pesceri, V. and Yeh, E. T. (1999), Circulation 100, 2124–2126.
Roubey, R. A. S. (1996), Arthritis Rheum. 39, 1444–1454.
Roubey, R. A. S. (1998), Lupus 7, S114-S119.
De Groot, P., Bouma, B., Lutters, B. C. H., Simmelink, J. A., Derksen, R. H. W. M. and Gros, P. (2000), J. Autoimm. 15, 87–90.
Reddel, S. W., Wang, Y. X., Sheng, Y. H., and Krilis, S. A. (2000), J. Autoimmun. 15, 91–96.
Koike, T., Ichikawa, K., Atsumi, T., Kasahara, H., and Matsuura, E. (2000), J. Autoimm. 15, 97–100.
George, J., Harats, D., Gilburd, B., Afek, A., Shaish, A., Kopolovic, J., and Shoenfeld, Y. (2000), Circulation 102, 1822–1827.
George, J., Harats, D., Gilburd, B., Afek, A., Shaish, A., Kopolovic, J., and Shoenfeld, Y. (2000), Circulation 102, 1822–1827.
Maron, D. J., Fazio, S., and Linton, M. F. (2000), Circulation 101, 207–213.
Sacks, F. M. (2001), Am. J. Cardiol. 88, 14N-18N.
Bellosta, S., Ferri, N., Bernini, F., Paoletti, R., and Corsini, A. (2000), Ann. Med. 32, 164–176.
Delerive, P., Fruchart, J. C., and Staels, B. (2001), J. Endocrinol. 169, 453–459.
Farmer, J. A. (2000), Current Atherosclerosis Reports 2, 208–217.
Koh, K. K. (2000), Cardiovasc. Res. 47, 648–657.
Wheeler, D. C. (1998), Drugs 56, 517–522.
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., et al. (2001), Nature Med. 7, 687–692.
Hernandez-Perera, O., Perez-Sala, D., Navarro-Antolin, J., Sanchez-Pascuala, R., Hernandez, G., Diaz, C., and Lamas, S. (1998), J. Clin. Invest. 101, 2711–2719.
Hausding, M., Witteck, A., Rodriguez-Pascual, F., von Eichel-Streiber, C., Forstermann, U., and Kleinert, H. (2000), Br. J. Pharmacol. 131, 553–561.
Laufs, U., Endres, M., Custodis, F., Gertz, K., Nickenig, G., Liao, J. K., and Bohm, M. (2000), Circulation 102, 3104–3110.
Feron, O., Dessy, C., Desager, J. P., and Balligand, J. L. (2001), Circulation 103, 113–118.
Laufs, U., La Fata, V., Plutzky, J., and Liao, J. K. (1998), Circulation 97, 1129–1135.
Inoue I, Goto S, Mizotani K, Awata T, Mastunaga T, Kawai S, et al. (2000), Life Sci. 67, 863–876.
Kothe, H., Dalhoff, K., Rupp, J., Muller, A., Kreuzer, J., Maass, M., and Katus, H. A. (2000), Circulation 101, 1760–1763.
Mueck, A. O., Seeger, H., and Wallwiener, D. (2001), Exp. Clin. Endocrinol. Diabetes 109, 181–183.
Meroni, P. L., Raschi, E., Testoni, C., Tincani, A., Balestrieri, G., Molteni, R., et al. (2001), Arthritis Rheum. 44, 2870–2878.
Sadeghi, M. M., Collinge, M., Pardi, R., and Bender, J. R. (2000), J. Immunol. 165, 2712–2718.
Niwa, S., Totsuka, T., and Hayashi, S. (1996), Int. J. Immunopharm. 18, 669–675.
Hackman, A., Abe, Y., Insull, W., Jr., Pownall, H., Smith, L., Dunn, K., et al. (1996), Circulation 93, 1334–1338.
Romano, M., Mezzetti, A., Marulli, C., Ciabattoni, G., Febo, F., Di Ienno, S., et al. (2000), J. Invest. Med. 48, 183–189.
Murphy, R. T., Foley, J. B., Mulvihill, N., Crean, P., and Walsh, M. J. (2001), Am. J. Cardiol. 87, 446–448.
Kwak, B., Mulhaupt, F., Myit, S., and Mach, F. (2000), Nature Med. 6, 1399–1402.
Sadeghi, M. M., Tiglio, A., Sadigh, K., O'Donneil, L., Collinge, M., Pardi, R., and Bender, J. R. (2001), Transplantation 71, 1262–1268.
Seeger, H., Mueck, A. O., and Lippert, T. H. (2000), Int. J. Clin. Pharmacol. Ther. 38, 270–272.
Hernandez-Perera, O., Perez-Sala, D., Soria, E., and Lamas, S. (2000), Circulation Res. 87, 616–622.
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., and Walsh, K. (2000), Nature Med. 6, 1004–1010.
Vincent, L., Chen, W., Hong, L., Mirshahi, F., Mishal, Z., Mirshahi-Khorassani, T., et al. (2001), FEBS Lett. 495, 159–166.
Vasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A. M., and Dimmeler, S. (2001), Circulation 103, 2885–2890.
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., and Braunwald, E. (1999), Circulation 100, 230–235.
Strandberg, T. E., Vanhanen, H., and Tikkanen, M. J. (1999), Lancet 353, 118–119.
Musial, J., Undas, A., Gajewski, P., Jankowski, M., Sydor, W., and Szczeklik, A. (2001), Int. J. Cardiol. 77, 247–253.
Jialal, I., Stein, D., Balis, D., Grundy, S. M., Adams-Huet, B., and Devaraj, S. (2001), Circulation 103, 1933–1935.
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., and PRINCE Investigators. (2001), JAMA 286, 64–70.
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., Gotto, A. M., Jr., and Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. (2001), N. Engl. J. Med. 344 1959–1965.
Rosenson, R. S., Tangney, C. C., and Casey, L. C. (1999), Lancet 353, 938–984.
Romano, M., Diomede, L., Sironi, M., Massimiliano, L., Sottocorno, M., Polentarutti, N., et al. (2000), Lab. Invest. 80, 1095–1100.
Diomede, L., Albani, D., Sottocorno, M., Donati, M. B., Bianchi, M., Fruscella, P., and Salmona, M. (2001), Arterioscler. Thromb. Vasc. Biol. 21, 1256–1258.
Martinez-Gonzalez, J., Alfon, J., Berrozpe, M., and Badimon, L. (2001), Atherosclerosis 159, 27–33.
Sparrow, C. P., Burton, C., Hernandez, M., Mundt, S., Hassing, H., Patel, S. et al. (2001), Arterioscler. Thromb. Vasc. Biol. 21, 115–121.
Stalker, T. J., Lefer, A. M., and Scalia, R. (2001), Br. J. Pharmacol. 133, 406–412.
Fischetti, F., Meroni, P. L., Pausa, M., Macor, P., Stebel, M., and Tedesco, F. Proceedings of the XVth Meeting of the Italian Society of Immunology and Clinical Immunology; Rome, 19–21 September, 2001.
Lopez, S., Peiretti, F., Bonardo, B., Deprez-Beauclair, P., Laouenan, H., Juhan-Vague, I., and Nalbone, G. (2001), J. Cardiovasc. Pharmacol. 37, 762–768.
Wiesbauer, F., Kaun, C., Zorn, G., Maurer, G., Huber, K., and Wojta, J. (2002), Br. J. Pharmacol. 135, 284–292.
Colli, S., Eligini, S., Lalli, M., Camera, M., Paoletti, R., and Tremoli, E. (1997), Arterioscler. Thromb. Vasc. Biol. 17, 265–272.
Camera, M., Maderna, P., Gaviraghi, M., and Tremoli, E. (1996), Atherosclerosis 133, 269.
Holschermann, H., Hilgendorff, A., Kemkes-Matthes, B., Schonburg, M., Bauer, E. P., Tillmanns, H., and Haberbosch, W. (2000), Transplantation 69, 1830–1836.
Cutts, J. L. and Bankhurst, A. D. (1989), Int. J. Immunopharmacol. 11, 863–869.
Kurakata, S., Kada, M., Shimada, Y., Komai, T., and Nomoto, K. (1996), Immunopharmacology 34, 51–61.
Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., et al. (1995), N. Engl. J. Med. 333, 621–627.
Katznelson, S., Wilkinson, A. H., Kobashigawa, J. A., Wang, X. M., Chia, D., Ozawa, M., et al. (1996), Transplantation 61, 1469–1474.
Jenkins, G. H., Grieve, L. A., Yacoub, M. H., and Singer, D. R. (1996), Am. J. Cardiol. 78, 1453–1456.
Katznelson, S., Wang, X. M., Chia, D., Ozawa, M., Zhong, H. P., Hirata, M. et al. (1998), J. Heart Lung Transpl. 17, 335–340.
Meroni, P. L. and Riboldi, P. (2001), Curr. Opin. Rheumatol. 13, 377–382.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meroni, P.L., Luzzana, C. & Ventura, D. Anti-inflammatory and immunomodulating properties of statins. Clinic Rev Allerg Immunol 23, 263–277 (2002). https://doi.org/10.1385/CRIAI:23:3:263
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:23:3:263